Yucheng Wu Selected Research

Complement C3 (C3 Complement)

8/2019

Serum levels of immunoglobulin G and complement 3 differentiate non-diabetic renal disease from diabetic nephropathy in patients with type 2 diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yucheng Wu Research Topics

Disease

15	Type 2 Diabetes Mellitus (MODY) 12/2023 - 01/2016
14	Diabetic Nephropathies (Diabetic Nephropathy) 03/2024 - 07/2018
13	Chronic Kidney Failure (Chronic Renal Failure) 02/2023 - 07/2018
12	Proteinuria 12/2023 - 07/2018
6	Fibrosis (Cirrhosis) 12/2023 - 01/2019
6	Atrophy 12/2023 - 01/2019
6	Inflammation (Inflammations) 01/2023 - 06/2019
5	Hypertension (High Blood Pressure) 01/2022 - 01/2019
5	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2020 - 07/2018
4	Chronic Renal Insufficiency 04/2023 - 01/2019
2	Heart Failure 04/2023 - 10/2020
2	Body Weight (Weight, Body) 01/2023 - 08/2015
2	Atrial Fibrillation 01/2022 - 01/2022
2	Insulin Resistance 12/2021 - 01/2016
1	Leg Ulcer 04/2024
1	Albuminuria 01/2024
1	Obesity 01/2023
1	Metabolically Benign Obesity 01/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Hyperglycemia 01/2023
1	AIDS-Related Complex (ARC) 09/2022
1	Stroke (Strokes) 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2021
1	Latent Autoimmune Diabetes in Adults 12/2021
1	Hypotension (Low Blood Pressure) 10/2020
1	Hypoxia (Hypoxemia) 07/2020
1	Bundle-Branch Block (Fascicular Block) 01/2020
1	Diabetes Mellitus 06/2019
1	Anemia 06/2019
1	Neoplasms (Cancer) 01/2019
1	Conversion Disorder (Astasia Abasia) 08/2018
1	Renal Insufficiency (Renal Failure) 07/2018
1	Stomach Neoplasms (Stomach Cancer) 03/2016
1	Coronary Disease (Coronary Heart Disease) 01/2015
1	Lung Neoplasms (Lung Cancer) 01/2014
1	Reperfusion Injury 06/2013
1	Brain Ischemia (Cerebral Ischemia) 06/2013

Drug/Important Bio-Agent (IBA)

6	Glucose (Dextrose)FDA LinkGeneric 04/2023 - 01/2016
5	Serum AlbuminIBA 02/2023 - 01/2019
5	Hemoglobins (Hemoglobin)IBA 02/2023 - 04/2020
5	CholesterolIBA 01/2023 - 04/2020
3	AlbuminsIBA 01/2024 - 01/2022
3	LipidsIBA 01/2023 - 01/2022
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 08/2019 - 01/2019
3	GoldIBA 03/2016 - 06/2013
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 04/2023 - 12/2021
2	Proteins (Proteins, Gene)FDA Link 02/2023 - 04/2020
2	CreatinineIBA 01/2023 - 01/2019
2	Uric Acid (Urate)IBA 01/2022 - 10/2021
2	Insulin (Novolin)FDA Link 01/2022 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 04/2020
2	IncretinsIBA 12/2021 - 10/2020
2	Fibrinogen (Factor I)FDA Link 11/2019 - 07/2018
1	DNA (Deoxyribonucleic Acid)IBA 03/2024
1	HDL CholesterolIBA 01/2024
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2023
1	pro-brain natriuretic peptide (1-76)IBA 12/2023
1	Endothelin Receptor AntagonistsIBA 04/2023
1	pirfenidoneIBA 04/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2023
1	Pentoxifylline (Trental)FDA LinkGeneric 04/2023
1	SodiumIBA 04/2023
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 04/2023
1	Dipeptidyl-Peptidase IV InhibitorsIBA 04/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2023
1	Liraglutide FDA Link 01/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	AlloysIBA 09/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	C-PeptideIBA 12/2021
1	Indicators and Reagents (Reagents)IBA 12/2021
1	C-Reactive ProteinIBA 10/2020
1	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2020
1	tungsten oxideIBA 07/2020
1	Vitamin D FDA LinkGeneric 01/2020
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2020
1	hydroxide ionIBA 01/2020
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Immunoglobulin G (IgG)IBA 08/2019
1	Complement C3 (C3 Complement)IBA 08/2019
1	BilirubinIBA 06/2019
1	Heme Oxygenase-1IBA 06/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	CR 39 (CR39)IBA 01/2019
1	Cystatin CIBA 01/2019
1	LithiumIBA 08/2018
1	Oxygen (Dioxygen)IBA 08/2018
1	Interleukin-1 Type I ReceptorsIBA 01/2015
1	Citric Acid (Citrate)FDA LinkGeneric 06/2013

Therapy/Procedure

9	Therapeutics 01/2022 - 06/2013
2	Renal Replacement Therapy (Therapies, Renal Replacement) 08/2019 - 01/2019
2	Aftercare (After-Treatment) 03/2016 - 01/2014
1	Magnetic Field Therapy 04/2024
1	Radiofrequency Ablation 01/2022
1	Cardiac Rehabilitation 01/2022
1	Cardiac Resynchronization Therapy 01/2020
1	Electrodes (Electrode) 08/2018